Skip to content

A randomized controlled study of rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) and allogeneic bone in lateral anterior lumbar interbody fusion (OLIF)

A randomized controlled study of rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) and allogeneic bone in lateral anterior lumbar interbody fusion (OLIF)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043375
Enrollment
Unknown
Registered
2021-02-12
Start date
2020-08-01
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar disease

Interventions

A:Upper intervertebral space filling with rhBMP-2 self-curing calcium phosphate artificial bone (granular) inferior intervertebral space filling artificial bone
B:Superior intervertebral space filling Allograft bone inferior intervertebral space filling rhBMP-2 self-curing calcium phosphate artificial bone (granular)

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The patients were diagnosed as L3-5 degenerative instability or degenerative spondylolisthesis within Meyerding grade II, and all patient with or without lumbar spinal stenosis; 2. Patients were suffering from Clinical symptoms correspond to radiological outcomes (such as chronic low back pain with or without lower limb radiative pain). 3. All patients had been underwent conservative treatment for > 6 months without effect; 4. Patients were at least 18 years old (skeletally mature); 5. Patients who agree with take part in this clinical study.

Exclusion criteria

Exclusion criteria: 1. The patients were diagnosed as servent lumbar scoliosis, isthmic spondylolisthesis, multiple lumbar degenerative stenosis(over 3 leverls), lumbar fractures, severe osteoporosis (T score less than -2.5), and degenerative spondylolisthesis classified as higher than Meyerding grade II; 2. Non-agreement between the radiological diagnosis and the clinical symptoms;

Design outcomes

Primary

MeasureTime frame
fusion rate;fusion percentage;

Countries

China

Contacts

Public ContactJiancheng Zeng

West China Hospital of Sichuan University

tomzeng5@vip.163.com+86 18980602091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026